PSYCHEDELICS MARKET

We Participated in the CPH placement - and so did Billionaire John Hancock

Mar 26, 2021

Creso Pharma (ASX: CPH) is edging closer to becoming part of our long term portfolio. CPH just raised $18M, which significantly shores up the balance sheet - another tick in the box for us as CPH builds trust to enter our long term portfolio.

CPH to be the First ASX Stock to Acquire 100% of a Psychedelics Company

Mar 15, 2021

Creso Pharma (ASX: CPH) will be the first ASX listed stock to acquire 100% of a psychedelics company. CPH is set to acquire Canada based Halucenex Life Sciences Inc., an established psychedelics company developing treatments for a range of mental illnesses.